drugset / Trial / NCT07566377

Cord Blood Transplantation in Children and Young Adults With Blood Cancer

NCT07566377 ↗

Phase 2 Recruiting 71 enrolled Memorial Sloan Kettering Cancer Center
Non-randomizedParallel-groupOpen-labelTreatment

Summary

The purpose of this study is to find out whether Cord Blood Transplantation/CBT as the first or second transplant is an effective treatment for children and young adults with blood cancer.

Timeline

Start
2026-04-28
Primary completion
2030-04-28
Completion
2030-04-28

Drugs

EvaluationDrugModalityDoseRoute
Subject Cord Blood Units Unknown — —
Background Busulfan Small molecule — —
Background Clofarabine Other / unclassified — —
Background Cyclophosphamide Other / unclassified — —
Background Cyclosporine Peptide — —
Background Fludarabine Small molecule — —
Background Mycophenolate Mofetil Small molecule — —
Background Tacrolimus Small molecule — —
Background Thiotepa Other / unclassified — —